Did You Know? Stem Cells are emerging as a New Hope for Lasting Dry Mouth Relief.

Mesenchymal Stem Cell therapies hold the potential to bring lasting relief from Xerostomia, not only easing the daily discomfort of dryness but also restoring the simple joys of speaking, eating, and living with ease.

Xerostomia is defined as the subjective perception of dry mouth. It can harm your oral health and quality of life... Let's face it.

Saliva plays an important role in oral health. It acts to protect against bacteria and fungi, transport of nutrients and digestive enzymes, lubrication of the oral cavity and remineralisation of the teeth, as well as helping to chew, swallow and speak. Saliva helps prevent tooth decay by neutralizing acids produced by bacteria, limiting bacterial growth and washing away food particles. In addition, enzymes in saliva aid in digestion.
Decreased saliva and dry mouth can range from being merely a nuisance to something that has a major impact on your general health and the health of your teeth and gums, as well as your appetite and enjoyment of food.

The Symptoms

Symptoms of Xerostomia include halitosis (bad breath), mouth pain and burning, difficulty swallowing and speaking, and taste disturbances (early clinical manifestations) and it can increase the risk of tooth decay and contribute to periodontal diseases and oral infections such as candidiasis (infection caused by the fungus Candida albicans).

  • Dryness or a feeling of stickiness in your mouth

  • Saliva that seems thick and stringy

  • Bad breath

  • Difficulty chewing, speaking and swallowing

  • Dry or sore throat and hoarseness

  • Dry or grooved tongue

  • A changed sense of taste

  • Problems wearing dentures

The Causes

The factors that can trigger Xerostomia include age, neurodegenerative diseases, head and neck cancer and autoimmune conditions (such as Sjögren’s syndrome, which exposes those affected to a high risk of Xerostomia).
Oropharyngeal dysphagia refers specifically to difficulty in initiating a swallow due to dysfunction at or above the upper esophageal sphincter, and represents a large proportion of dysphagia cases.

Chemotherapy and radiation therapy – head and neck cancer.

Despite major improvements in radiation therapy for head and neck cancer (HNC), the most prevalent long-term complications are radiation-induced salivary gland hypofunction and Xerostomia. The major salivary glands (SGs) are highly radiosensitive; ionizing radiation leads to reduced saliva flow rate and changes in both the composition and function of saliva. Consequently, patients may suffer from dental decay, oral infections, difficulties with speaking, chewing, and swallowing, sleep disturbance, worsened nutritional state, and impaired quality of life (QoL).
The pathophysiology behind radiation injury of SGs is multifactorial and includes an acute and late response that may continue for years, characterized by chronic inflammation, acinar, local progenitor and stem cell loss and the development of fibrosis and im- paired environment for surviving acinar cells.

Other Causes:

  • Tobacco and alcohol use. Drinking alcohol and smoking or chewing tobacco can increase dry mouth symptoms

  • Other health conditions. Dry mouth can be due to certain health conditions, such as diabetes, stroke, yeast infection (thrush) in your mouth or Alzheimer’s disease, or due to autoimmune diseases, such as Sjogren’s syndrome or HIV/AIDS. Snoring and breathing with your mouth open also can contribute to dry mouth.

  • Recreational drug use. Methamphetamine use can cause severe dry mouth and damage to teeth, a condition also known as “meth mouth.” Marijuana also can cause dry mouth.

Can’t wait to feel like yourself again?

How?

It’s easier than you think. Discover the world’s most advanced Stem Cell and Exosomes treatment. Reach out to us — we’re here for you and happy to answer any questions you may have.

Where?

Como (Italy)
Milano (Italy)
Rome (Italy)
Varese (Italy)
Falciano (RSM)

The Treatment

A large number of irradiated head and neck cancer patients worldwide are suffering from the harsh and long-lasting side effect of salivary gland (SG) Hypofunction and Xerostomia, hence the importance of reaching a curative treatment.
No efficient treatment exists to alleviate the burden of radiation-induced salivary gland hypofunction and xerostomia. Currently, only sparse symptomatic treatment is available to ease the discomfort of Xerostomia.

THERAPY

Regenerative MSCs therapy is considered a prospective curative treatment for salivary gland (SG) Hypofunction and Xerostomia. Stem cell therapy is a new and novel advancement that may fill a much-needed role in our treatment regimen.

Preclinical studies indicate that MSCs can restore radiation damaged lesions, and regenerate radiation-damaged SGs to produce more saliva through the release of hepatocyte growth factor, vascular endothelial growth factor, cyclooxygenase-2, and matrix metalloproteinase-2 and by increasing the density of blood vessels in the SGs. In a recent randomized trial, we found that autologous adipose tissue-derived mesenchymal stem cells injected into the submandibular glands of patients with radiation-induced Xerostomia to be safe with a promising tendency to restore submandibular gland function.

Methods

Twenty-five million MSCs are injected into each submandibular and 50 million MSCs into each parotid gland. It is already demonstrated that an allogeneic and autologous MSC therapy is safe and feasible and has a tendency toward clinical efficacy in patients with radiation-induced salivary gland hypofunction and xerostomia.

Results

A significant and clinically meaningful increase in unstimulated and stimulated whole saliva flow rate was observed along with decrease in xerostomia with improved patient-reported quality of life. The current literature topics regarding stem cell treatments for oropharyngeal dysphagia includes tissue regeneration advancements.
Functionally, they observed a 42% increase in saliva production in the cell injection group compared to untreated irradiated glands.

Stem Cell Procedure

Let’s clarify with accurate information:

Stem Cells obtained from a fat sample require at least two weeks of processing before they can be used; otherwise, the treatment is ineffective and potentially harmful:

  • Fat that is harvested and manipulated for use in the same session is both useless and harmful.
  • There are no Stem Cells in the blood, so treatments claiming to use stem cells extracted from blood are not scientifically valid. The Stem Cells used to treat hematological diseases are found in the bone marrow, not in the blood.
  • The hematopoietic stem cells found in umbilical cord blood are useful for treating blood disorders, but not for counteracting the aging processes of the human body

The Stem Cell Source

Mesenchymal stem cells are the same regardless of whether they are derived from Adipose Tissue or Umbilical Cord Tissue. The only difference lies in their biological age, which reflects the age of the tissue of origin.

Adipose Tissue Derived Stem Cells 

The treatment requires a fat collection, stem cell extraction, and expansion. The entire process takes approximately 2–3 weeks. Therefore, from the moment of fat harvesting, a waiting period of 2–3 weeks is necessary before the treatment can be performed.

Umbilical Cord Tissue derived Stem Cells

The treatment does not require fat harvesting and can be performed within 2–3 days of the request.

Contact us Today

Why?

Because you deserve to feel great again. To feel like yourself. The solution exists — it’s real, and it starts with your choice.

Where?

Como (Italy)
Milano (Italy)
Rome (Italy)
Varese (Italy)
Falciano (RSM)

Stromal Vascular Fraction (SVF) VS Mesenchymal Stem Cells (MSC)

In the regenerative medicine landscape, many providers offer therapies labeled as "Stem Cell treatments" that utilize Stromal Vascular Fraction (SVF)—a heterogeneous mix of cells extracted from adipose tissue. While SVF contains some Stem Cells, it also includes various other cell types, leading to variability in treatment outcomes.
At our Clinic, we prioritize precision and efficacy by exclusively using Mesenchymal Stem Cells (MSCs). These are meticulously isolated and expanded in controlled laboratory settings, ensuring a pure, potent, and standardized cell population. This approach enhances the therapeutic potential and consistency of our treatments.

Standard Product and Therapy

MSC
YES, A pharma-grade product derived from a cell isolation and culture process, subject to strict quality control procedures

SVF
NO, Composition varies based on the collection site, the patient’s biological age, the digestion technique used, and several other factors.

Cellular Homogeneity

MSC
YES, Isolated and phenotyped cells

SVF
NO, Heterogeneous cell population

Concentration of MSC

MSC
100%

SVF
Between 0,001% and 0,01% of the total cells within

MSC per 10ml FAT

MSC
>100.000.000 after expansion

SVF
Around 9.000

Microphages per 10ml FAT

MSC
0 - Eliminated through isolation of MSCs

SVF
>400.000

Side Effects

MSC
NO

SVF
YES, often unpredictable, usually mediated by inflammatory processes caused by the macrophage population or potential bacterial contamination

Dosage

MSC
VARIOUS DOSAGES AVAILABLE
10-200 millions of MSC (based on indications)

SVF
SINGLE DOSAGE
not tailored to treatment

Safety

MSC
Pharma-grade production process, subjected to quality controls that ensure product sterility and biological safety

SVF
The production process is not monitorable and not subject to quality and biological safety controls

Treatments from 1 fat Collection

MSC
≥10

SVF
1

Phenotyping

MSC
YES

SVF
NO

Cellular Composition

MSC
Mesenchymal Stem Cells

SVF
Pericytes, Macrophages, Endothelial Cells, Mesenchymal Stem Cells, Adipocytes, Lymphocytes, Fibroblasts

Quality Control

MSC
Endotoxins, Mycoplasma, Anaerobic/Aerobic Bacteria, Viruses, Phenotype

SVF
None

Production Time

MSC
2-4 Weeks

SVF
1 hour

FDA Approval

MSC
YES (Ryoncil 18-12-2024)

SVF
NO

EMA Approval

MSC
YES (Alofisel, Spherox, Ryoncil)

SVF
NO

Usage

MSC
Autologous and Allogenic Localized and Systemic

SVF
Strictly Autologous, Homologous, and Localized

    POWERED BY

    BioScience Institute

    As the world’s leading center of Stem Cell and Regenerative Medicine, Bioscience offers unparalleled service and treatments, unique only to it. Bioscience offers the most advanced personalized expanded adipose derived Stem Cell therapies across Europe – including Rome, Milan, and San Marino, and the Middle East, including Dubai.

    The team at Bioscience Institute does not believe in using invasive surgeries when they can be partially replaced by cell biology. Therefore, they have designed an alternative method of extracting stem cells from adipose tissue. As a distinctive and versatile offering, adipose tissue provides an effective solution to all of Bioscience regenerative services, ranging from to hair loss treatments, to skin aging, to body reshaping treatments.

    Bioscience Institute Vision

    The beauty of regenerative medicine therapies and Stem Cell treatments comes from the ability to use your own body to help heal and enhance your well-being through living body tissue. Bioscience Institute’s vision is based on using this most effective and advanced Stem Cell treatments that is based on cell biology and Exosomes to help amplify our natural healing process in the areas it is needed most or take over the function of damaged tissue altogether.

    Stem cells verified treatments

    With the ability to develop methods to regrow, repair, or replace damaged cells and tissues, using Stem Cell & regenerative medicines provides a natural method of treatment that is less traumatic to the body and more effective than other more invasive treatments and surgeries. The stem cell therapies provided by Bioscience Institute are verified in Europe and the Middle East by scientific evidence of increased safety and efficiency than any other treatment method.

    Scientific Research

    The Bioscience’s profits are consistently reinvested into developing research. Avoiding a flashy commercial profile allows us to concentrate on using investments to create better treatments and ultimately help clients globally. Due to this commitment, Bioscience Institute has instigated important scientific collaborations with leading universities, pioneering procedures and methods around cell products.

    Bioscience Cell Factory and Clinic in Dubai, San Marino, Italy & Switzerland

    Bioscience Institute is the first and only GMP-certified Clinic in the Middle East and Europe, offering stem cell treatments with the most advanced personalized autologous cell therapies worldwide.
    Offering a unique service and treatment sets it apart from any form of competition and allows it to give clients the care, attention, and treatment they deserve.

    • Bioscience Clinics in the Middle East and Europe include a fully equipped facility needed to carry out any treatments offered, whether Stem Cell treatments or banking.
    • Bioscience Laboratory is a dedicated Cell Banking Factory used to store and expand Adipose-Derived Cells and Fibroblasts to help ensure that the clients’ needs can always and easily be catered to.